Chinese Outbound Direct Investments (ODI) Law Practice

Overview

For decades, economic investment with China always meant investment into China. But during recent years, the tables have turned and outbound direct investments (ODIs) from China have become a common phenomenon. New global markets and emerging business models are driving Chinese enterprises outbound as these companies seek to expand their footprint in the global marketplace. While this brings exciting new opportunities for Chinese companies, navigating between countries—and the nuanced regulations of those countries—brings added complexity.

These global challenges require global resources. Which is why McDermott’s cross-disciplinary China-focused ODI team combines the deep international experience and business savvy of lawyers from the North American and European continents to best advise our China-based clients in your outbound business expansion, investment, acquisition, license and collaboration across the globe.

Results

Expansion in the US

A Beijing-based social media company, in connections with the acquisitions of:
- Aspiration, Inc., a California-based socially conscious online financial firm;
- Sindeo, Inc., a San Francisco-based mortgage services technology firm;
- Xue Qiu, a social network and information portal for investors in China;
- Plum Lending Inc., an online commercial real estate lending platform;
- Fundrise, an real estate crowdfunding platform;
- Fiscal Note, a legislative and regulatory analytics provider;
- CreditShop, a Texas based consumer lending company;
- LendingHome, a San Francisco-based mortgage lender;
- Motif Investing, a California-based investment trading platform; and
- Wise Banyan, a New York headquartered provider of a free financial advisory platform.
Renren, Inc. (NYSE: RENN) in connection with multiple acquisitions and strategic transactions

A global investment bank and a Chinese private equity fund, in connection with the acquisition of Circle Internet Financial, a Boston-based cryptocurrency-focused finance company
Dahua Technology, in connection with its US$29 million acquisition of Lorex Technology from FLIR
FC Capital, life science investing arm of one of China’s largest investment banks, in connection with its early stage life science investments
VcanBio Cell & Gene Engineering Co., Ltd., a leading Chinese life science company, in connection with its expansion in the US, including setting up subsidiaries and R&D center, collaboration and licensing arrangements, office building purchases, investments and acquisitions
A Chinese public company in connection with its acquisition of a US CRO business
A Chinese company in connection with its acquisition of a US carbon composite materials manufacturer
A Chinese technology company in connection with its outbound investments in the United States
A private equity firm and an insurance company in connection with the US$930 million purchase of a health care real estate portfolio consisting of 39 senior housing and assisted living facilities throughout 11 states in the US from Welltower Inc., a health care real estate investment trust (REIT)*
A leading China-based asset management company in connection with $50 million investment in a US medical device company*
A leading China-based asset management company in connection with $125 million convertible note financing to a real estate project located in New York City*
A leading Chinese investment company in connection with a proposed $100 million acquisition of a NASDAQ-listed biotechnology company*
A Chinese investment company in connection with its $50 million equity interest purchase of an international five-star hotel in the US
A large Chinese fiber-manufacturing group in connection with setting up its business operations in the US and acquiring the land and factory facilities for its operation; including internal tax structure and M&A legal advice
A Chinese real estate conglomerate in its US-bound commercial real estate investments, acquired to develop warehouse and storage facilities
One of the largest venture capital funds of a Chinese municipal government in its investments in high-tech companies on both the East and West Coasts of the US,
Family office of a well-known Chinese entrepreneur in connection with its acquisition of a biotechnology company in California
A number of multi-billion dollar global families on FATCA and CRS compliance strategies with respect to their business and financial assets held through complex structures in multiple continents
A high net worth Chinese family on their wealth holding structures that have a US Nexus, optimizing the US tax and disclosure impacts on US family members and their global assets
The major US founders of a Chinese biotech company on their wealth holding structures prior to the company’s approximately $1 billion initial public offering on the Hong Kong Stock Exchange
A sovereign wealth fund on the US tax aspects of its fund investments
A Chinese company that operates a leading public blockchain platform with respect to its global restructuring to address tax, securities and general corporate concerns in multiple jurisdictions

*Matter handled by current McDermott attorneys prior to joining McDermott

Show Less

Chinese Outbound Direct Investments (ODI)

Overview

Results

Expansion in the US

People

Key Contacts

Byron S. Kalogerou